Injections deliver vitamins directly into your bloodstream, offering faster replenishment and better absorption for long-term benefits
Caruso I, Marrano N, Biondi G et al (2023) Glucagon in type 2 diabetes: friend or foe
Every medication has trade-offs, and youll want to discuss the potential benefits and risks with your doctor based on your unique health history
Research shows that 73% of patients don't receive education about foods that naturally boost GLP-1 production, leaving tremendous potential on the table

mechanism unexplained Relative contributions of direct peptide effects versus downstream IGF-1 actions inadequately characterized Long-term receptor sensitivity and potential for desensitization inadequately studied Individual patient variability in response not well-characterized Potential for differential effects based on endogenous growth hormone status unclear Long-Term Safety Considerations Critical safety questions remain unanswered regarding chronic peptide administration: Cardiovascular safety concerns FDA warnings cite risks of increased heart rate, systemic vasodilation, flushing, and transient hypotension Immunogenicity risks FDA identifies both peptides as potentially immunogenic with risk of serious immune reactions including anaphylaxis Cancer risk theoretical concern that chronic growth hormone/IGF-1 elevation could promote cellular proliferation
Will continue to purchase from Citizen Meds